Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Prostate Cancer and Prostatic Diseases|April 8, 2004
Proteasome inhibitors and their combination with antiandrogens: effects on apoptosis, cellular proliferation and viability of prostatic adenocarcinoma cell culturesT Zwergel, A Tahmatzopoulos, B Wullich, et al.
Urologia Internationalis|January 1, 1992
Cytogenetic evidence of intratumoral focal heterogeneity in prostatic carcinomasB Wullich, T Breitkreuz, T Zwergel, et al.
Der Urologe. Ausg. A|January 30, 2010
[Educational initiative of the German Society of Urology for innovative research : Workshops 2009]K-D Sievert, G Unteregger, R Nawroth, et al.
Electrophoresis|September 1, 1992
Genetic heterogeneity of prostatic carcinoma-derived cell lines as emphasized by DNA fingerprintingS Bettink, B Wullich, A Christmann, et al.
Aktuelle Urologie|November 5, 2004
[Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer]A Tahmatzopoulos, C Gudegast, M Stöckle, et al.
British Journal of Urology|December 5, 1998
p53 autoantibodies in patients with urological tumoursC Lang, G Unteregger, S Kartarius, et al.
The Prostate|June 1, 1996
Selection toward diploid cells in prostatic carcinoma derived cell culturesR Ketter, T Zwergel, K Romanakis, et al.
American Journal of Respiratory Cell and Molecular Biology|October 6, 1997
Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4C Büttner, A Skupin, T Reimann, et al.
Cancer Letters|September 30, 1999
Two different forms of p53 localized differently within cells of urogenital tumoursJ Benninghoff, S Kartarius, Z Teleb, et al.
Cancer Research|September 1, 1993
Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization studyT Breitkreuz, K Romanakis, S Lutz, et al.
Pageof 4